BeiGene
BGNE
$148.85
Share price
-3.50%
Change (1 day)
-33.39%
Change (1 year)
Categories
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.
Number of shares outstanding for BeiGene (BGNE)
Number of shares outstanding as of June 2024 : 104,272,894
According to BeiGene 's latest financial reports and stock price the company's current number of shares outstanding is 104,272,894. At the end of 2024 the company had 104,272,894 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for BeiGene from 2015 to 2024
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2024 | 0.10 B | -0.38% |
| 2023 | 0.10 B | 0.87% |
| 2022 | 0.10 B | 9.19% |
| 2021 | 95.02 M | 4.6% |
| 2020 | 90.84 M | 49.7% |
| 2019 | 60.68 M | 2.19% |
| 2018 | 59.38 M | 30.39% |
| 2017 | 45.54 M | 14.78% |
| 2016 | 39.67 M | 25.9% |
| 2015 | 31.51 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 706,882,189 | 577.92% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 21,043,458 | -79.82% | 🇺🇸 USA |